Unilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap After Breast Cancer
RMSU-LDPEM
1 other identifier
observational
22
1 country
1
Brief Summary
The use of pedicled dorsal flaps sparing the latissimus dorsi muscle (TDAP and MSLD flap) is a well-described reconstruction method in breast reconstruction after breast cancer. However, little data exists regarding patient satisfaction after this surgery. The main objective of this study was to evaluate patient satisfaction after unilateral total secondary breast reconstruction using a TDAP or MSLD flap.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedFebruary 28, 2024
January 1, 2024
5 months
January 8, 2024
February 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Patient satisfaction
patient satisfaction by using BREAST questionnaire (0 to 100, and 100 is the best score)
5 years
Secondary Outcomes (1)
Patient characteristics
5 years
Eligibility Criteria
Women who underwent unilateral secondary total breast reconstruction using a TDAP or MSLD flap.
You may qualify if:
- Breast reconstruction using a TDAP or MSLD flap between January 1, 2018 and December 31, 2022
- Major
- Non opposition
- Women with social security number
You may not qualify if:
- Bilateral reconstruction
- Partial reconstruction
- Immediate reconstruction
- Prophylactic reconstruction
- Women who did'nt have a breast cancer
- Women who don't finish their reconstruction
- Women who don't want participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Brest
Brest, 29609, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 30, 2024
Study Start
October 1, 2023
Primary Completion
February 28, 2024
Study Completion
February 28, 2024
Last Updated
February 28, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning three years and ending fifteen years following the final study report completion
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
All collected data that underlie results in a publication